[A case of unresectable and multiple advanced primary @entity5 of the stomach and rectosigmoid colon with hepatic metastases successfully treated with FOLFIRI for local control of a XXXX ].

@entity1 @entity11730 @entity298 @entity5 @entity1819 @entity344 @entity1726 @entity1321 @entity14 @entity99 @entity356
The @entity1 was a 59-year-old @entity1 who was hospitalized at our department for @entity1321 . Contrast enhanced abdominal CT showed a @entity5 invading the left pelvic wall and multiple metastatic @entity99 . Colonoscopy showed a type-2 @entity5 in the rectosigmoid region. The @entity1 underwent sigmoid colostomy 3 days after admission. Postoperative upper @entity344 showed a type 3 @entity5 in the fornix. From the above findings, the @entity1 was diagnosed with unresectable @entity356 with multiple hepatic metastases, and systemic chemotherapy was initiated. The first line treatment was two courses of @entity11730 , but it was discontinued due to @entity1726 . FOLFIRI was begun as the second line treatment. After 5 courses of FOLFIRI, upper @entity344 showed a marked reduction in @entity5 size. Twelve courses of FOLFIRI chemotherapy were performed in total. Subsequently, 11 courses of mFOLFOX6 and 1 course of RPMI were performed, but the @entity1 died from @entity298 . However, the @entity1819 had been controlled well after the second line treatment. The findings of the present study suggested that FOLFIRI could be an effective treatment for unresectable multiple advanced @entity5 of the stomach and @entity14 .
